Cancer vaccine adjuvants – recent clinical progress and future perspectives
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer vaccine adjuvants – recent clinical progress and future perspectives
Authors
Keywords
-
Journal
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
Volume 37, Issue 1, Pages 1-11
Publisher
Informa UK Limited
Online
2014-10-16
DOI
10.3109/08923973.2014.971963
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- Vaccine adjuvants: in search of new paradigms
- (2013) Nikolai Petrovsky Expert Review of Vaccines
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model
- (2013) Mark R. Schleiss et al. VACCINE
- Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants
- (2012) Colleen Olive Expert Review of Vaccines
- Clinical Applications of DNA Vaccines: Current Progress
- (2011) B. Ferraro et al. CLINICAL INFECTIOUS DISEASES
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- New adjuvants for human vaccines
- (2010) M Lamine Mbow et al. CURRENT OPINION IN IMMUNOLOGY
- Novel tuberculosis vaccination strategies based on understanding the immune response
- (2010) S. H. E. Kaufmann JOURNAL OF INTERNAL MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Adjuvants for cancer vaccines
- (2010) Thomas W. Dubensky et al. SEMINARS IN IMMUNOLOGY
- Unmet needs in modern vaccinology
- (2010) Geert Leroux-Roels VACCINE
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
- (2009) Jörg Vollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®
- (2009) Tino F. Schwarz ADVANCES IN THERAPY
- Clinical and Immunologic Basis of Interferon Therapy in Melanoma
- (2009) Ahmad A. Tarhini et al. Annals of the New York Academy of Sciences
- Pathogen recognition in the innate immune response
- (2009) Himanshu Kumar et al. BIOCHEMICAL JOURNAL
- Mechanism of action of clinically approved adjuvants
- (2009) Bart N Lambrecht et al. CURRENT OPINION IN IMMUNOLOGY
- The path to a successful vaccine adjuvant – ‘The long and winding road’
- (2009) Derek T. O’Hagan et al. DRUG DISCOVERY TODAY
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
- (2009) Amy B Heimberger et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Topical resiquimod: a promising adjuvant for vaccine development?
- (2009) Manoli Igartua et al. Expert Review of Vaccines
- Characterization of a murine keyhole limpet hemocyanin (KLH)-delayed-type hypersensitivity (DTH) model: Role for p38 kinase
- (2009) Laura Engstrom et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Heat shock proteins and immune system
- (2009) Min-Fu Tsan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma
- (2009) John M. Timmerman et al. LEUKEMIA & LYMPHOMA
- ISCOMs and ISCOMATRIX™
- (2009) Hong-Xiang Sun et al. VACCINE
- Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
- (2009) B. Jasani et al. VACCINE
- Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
- (2009) Susan L. Baldwin et al. VACCINE
- Alum adjuvanticity: Unraveling a century old mystery
- (2008) Ennio De Gregorio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines
- (2008) Q. Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search